Albemarle (ALB) Tops Q2 EPS by 45c; Offers FY22 Guidance

Albemarle (NYSE: ALB) reported Q2 EPS of $3.45, $0.45 better than the analyst estimate of $3.00. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.43 billion.

GUIDANCE:

Albemarle sees FY2022 EPS of $19.25-$22.25, versus the consensus of $15.87. Albemarle sees FY2022 revenue of $7.1-7.5 billion, versus the consensus of $6.89 billion.

For earnings history and earnings-related data on Albemarle (ALB) click here.

You May Also Be Interested In

• Medtronic (MDT) Tops Q1 EPS by 6c, Beats on Revenue; Offers FY27 EPS Guidance
• Morgan Stanley upgrades Robinhood, sees 43% upside
• Take-Two Interactive (TTWO) Reiterated at Buy by StoneX Ahead of November GTA VI Launch